From the publishers of JADPRO

Gastrointestinal Stromal Tumor Resource Center

Advertisement

Prolonged survival of a case with three different malignancies - cutaneous malignant melanoma, gastrointestinal stromal tumor and thyroid papillary cancer: A case report

Last Updated: Wednesday, August 6, 2025

This case report details a patient with an exceptionally rare combination of three primary cancers: Gastrointestinal stromal tumor (GIST), papillary thyroid carcinoma (PTC), and cutaneous malignant melanoma. The patient received comprehensive, multidisciplinary treatment including surgery and imatinib for GIST, thyroidectomy for PTC, and various systemic and local therapies for metastatic melanoma. Despite the melanoma's poor prognosis, the patient achieved prolonged survival, underscoring the effectiveness of integrated, targeted oncological approaches.

Oncology Letters
Advertisement
News & Literature Highlights

NPJ Precision Oncology

KIT mutation-NTRK fusion oncogenic driver switch: A novel mechanism of acquired imatinib resistance in GIST

Case Reports in Oncological Medicine

Pelvic gastrointestinal stromal tumor (GIST) mimicking ovarian cancer in a kidney-liver transplant recipient under chronic immunosuppression

Updates in Surgery

Laparoscopic resection for gastric gastrointestinal stromal tumor at the esophagogastric junction: Feasibility and long-term results

Life

Nationwide multicenter study of advanced endoscopic resection and malignant risk model for gastric myogenic tumors (GASTRO Trial)

Digestive Endoscopy

Endoscopic diagnosis of gastric subepithelial lesions < 20 mm: Current strategies and emerging solutions

Experimental Oncology

Diagnosis and surgical treatment of gastrointestinal stromal tumors of the stomach using minimally invasive technologies

International Journal of Surgical Pathology

Sporadic multiple gastrointestinal stromal tumors with distinct KIT and PDGFRA mutations in two separate tumors: A case report and literature review

Journal of Cancer Research and Therapeutics

A rare entity of esophageal gastrointestinal stromal tumor with literature review

World Journal of Gastrointestinal Oncology

FGFR2 fusions as novel oncogenic drivers in gastrointestinal stromal tumors: Two case reports and review of literature

Journal of Cellular and Molecular Medicine

The mechanisms of imatinib resistance in gastrointestinal stromal tumours: Theoretical basis and therapeutic aspect

Advertisement
Advertisement